Molecular recognition of viral infections- Immune response stimulation;Molekularne rozpoznawanie zakazen wirusowych- Stymulacja odpowiedzi immunologicznej

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 65, Issue , 2011, Pages 299-313

  Gieryńska, Małgorzata ^a   Schollenberger, Ada ^a  

^a SGGW w Warszawie   (Poland)

Author keywords

Cellular receptors; Immune response stimulation; Interferons; Nucleic acids; Proinflammatory cytokines; Viral infection

Indexed keywords

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; BACTERIAL INFECTIONS; HUMANS; IMMUNITY, INNATE; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 79958837640     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.945199     Document Type: Review

References (75)

1. Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V.: RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol., 2009; 10: 1065-1072.
2. Akira S., Takeda K.: Toll-like receptor signalling. Nat. Rev. Immunol., 2004; 4: 499-511. (Pubitemid 38931765)
3. Ank N., Paludan S.R.: Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors, 2009; 35: 82-87.
4. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., Paludan S.R.: Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against selected vi-rus infections in vivo. J. Virol., 2006; 80: 4501-4509.
5. Arimoto K., Takahashi H., Hishiki T., Konishi H., Fujita T., Shimotohno K.: Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. USA, 2007; 104: 7500-7505. (Pubitemid 47185935)
6. Bauernfeind F., Ablasser A., Bartok E., Kim S., Schmid-Burgk J., Cavlar T., Hornung V.: Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci., 2011; 68: 765-783.
7. Boo K.H., Yang J.S.: Intrinsic cellular defenses against virus infection by antiviral type I interferon. Yonsei Med. J., 2010; 51: 9-17.
8. Cheng G., Zhong J., Chung J., Chisari F.V.: Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc. Natl. Acad. Sci. USA, 2007; 104: 9035-9040. (Pubitemid 47175432)
9. Chi H., Flavell R.A.: Innate recognition of non-self nucleic acids. Genome Biol., 2008; 9: 211.1-211.7.
10. Chiu Y.H., Macmillan J.B., Chen Z.J.: RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell, 2009; 138: 576-591.
11. Colonna M.: TLR pathways and IFN regulatory factors: to each its own. Eur. J. Immunol., 2007; 37: 306-309. (Pubitemid 46915569)
12. Diebold S.S.: Recognition of viral single-stranded RNA by Toll-like receptors. Adv. Drug Deliv. Rev., 2008; 60: 813-823.
13. Dinarello C.A.: Immunological and inflammatory functions of the interleukin-1 family. Ann. Rev. Immunol., 2009; 27: 519-550.
14. Eberl G., Boneca I.G.: Bacteria and MAMP-induced morphogenesis of the immune system. Curr. Opin. Immunol., 2010; 22: 448-454.
15. Fernandes-Alnemri T., Wu J., Yu J.W., Datta P., Miller B., Jankowski W., Rosenberg S., Zhang J., Alnemri E.S.: The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ., 2007; 14: 1590-1604. (Pubitemid 47278845)
16. Fink S.L., Cookson B.T.: Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun., 2005; 73: 1907-1916. (Pubitemid 40470787)
17. Garcia-Sastre A.: Mechanisms of inhibition of the host interferon a/b-mediated antiviral responses by viruses. Microbes Infect., 2002; 4: 647-655. (Pubitemid 34607414)
18. Gilliet M., Cao W., Liu Y.J.: Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol., 2008; 8: 594-606.
19. Goodman M.G.: A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine. Pharm. Biotechnol., 1995; 6: 581-609.
20. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo S., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S.: Small anti-viral compounds activate immune cells via TLR7 MyD88-dependent signaling pathway. Nat. Immunol., 2002; 3: 196-200. (Pubitemid 34141451)
21. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S.: A Toll-like receptor recognizes bacterial DNA. Nature, 2000; 408: 740-745. (Pubitemid 32015992)
22. Hochrein H., Schlatter B., O'Keeffe M., Wagner C., Schmitz F., Schiemann M., Bauer S., Suter M., Wagner H.: Herpes simplex virus type-1 induces IFN-a production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA, 2004; 101: 11416-11421. (Pubitemid 39038361)
23. Honda K., Takaoka A., Taniguchi T.: Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity, 2006; 25: 349-360. (Pubitemid 44354220)
24. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T.: IRF-7 is the master regulator of type-I interferon-dependent immune respon-ses. Nature, 2005; 434: 772-777. (Pubitemid 44739521)
25. Hornung V., Ablasser A., Charrell-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., Latz E., Fitzgerald K.A.: AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC. Nature, 2009; 458: 514-518.
26. Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., Hartmann G.: 5'-Triphosphate RNA is the ligand for RIG-I. Science, 2006; 314: 994-997.
27. Hornung V., Latz E.: Intracellular DNA recognition. Nat. Rev. Immunol., 2010; 10: 123-130.
28. Horvath, C.M.: The Jak-STAT pathway stimulated by interferon alpha or interferon beta. Sci. STKE, 2004: tr10.
29. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematsu S., Kawai T., Takeuchi O., Akira S.: A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol., 2006; 7: 40-48. (Pubitemid 41823867)
30. Ishikawa H., Barber G.N.: STING is an endoplasmic reticulum adaptor that facilitates innate immune signaling. Nature, 2008; 455: 674-678.
31. Iwasaki A., Medzhitow R.: Toll-like receptor control of the adaptive immune responses. Nat. Immunol., 2004; 5: 987-995. (Pubitemid 41057715)
32. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., Akira S.: Length-dependent recognition of double stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med., 2008; 205: 1601-1610. (Pubitemid 351962024)
33. Klinman D.M.: Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol., 2004; 4: 249-258. (Pubitemid 38478660)
34. Komuro A., Horvath C.M.: RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J. Virol., 2006; 80: 12332-12342. (Pubitemid 44904383)
35. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P.: IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol., 2003; 4: 69-77. (Pubitemid 36109115)
36. Kumagai Y., Takeuchi O., Akira S.: TLR9 as a key receptor for the recognition of DNA. Adv. Drug Deliv. Rev., 2008; 60: 795-804.
37. Lamkanfi M., Dixit V.M.: Inflammasomes: guardians of cytosolic sanctity. Immunol. Rev., 2009; 227: 95-105.
38. Lazzaro B.P, Rolff J.: Danger, microbes and homeostasis. Science, 2011; 332: 43-44.
39. Marrack P., Kappler J., Mitchell T.: Type I interferons keep activated T cells alive. J. Exp. Med., 1999; 189: 521-530.
40. Martinon F., Mayor A., Tschopp J.: The inflammasomes: guardians of the body. Annu. Rev. Immunol., 2009; 27: 229-265.
41. Martinon F., Tschopp J.: Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell, 2004; 117: 561-574. (Pubitemid 38692523)
42. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., Yamamoto A., Seya T.: Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol., 2003; 171: 3154-3162. (Pubitemid 37093540)
43. McCartney S.A., Colonna M.: Viral sensors: diversity in pathogen recognition. Immunol. Rev., 2009: 227: 87-94.
44. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., Tschopp J.: RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kB activation. Nat. Immunol., 2004; 5: 503-507. (Pubitemid 38660462)
45. Modlin R.L.: A Toll for DNA vaccines. Nature, 2000; 408: 659-660. (Pubitemid 32015968)
46. Morrison L.A.: The Toll of herpes simplex virus infection. Trends Microbiol., 2004; 12: 353-356. (Pubitemid 38987820)
47. Muruve D.A., Pétrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., Parks R.J., Tschopp J.: The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature, 2008; 452: 103-107. (Pubitemid 351355095)
48. Pasare C., Medzhitov R.: Toll-like receptors: linking innate and adaptive immunity. Microbes Infect., 2004; 6: 1382-1387. (Pubitemid 41110581)
49. Pirher N., Ivičak K., Pohar J., Benčina M., Jerala R.: A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation. Nat. Struct. Mol. Biol., 2008; 15: 761-763. (Pubitemid 351932009)
50. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., Vanaja S.K., Monks B.G., Ganesan S., Latz E., Hornung V., Vogel S.N., Szomolanyi-Tsuda E., Fitzgerald K.A.: The AIM2 in-flammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol., 2010; 11: 395-402.
51. Roberts T.L., Idris A., Dunn J.A., Kelly G.M., Burnton C.M., Hodgson S., Hardy L.L., Garceau V., Sweet M.J., Ross I.L., Hume D.A., Stacey K.J.: HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science, 2009; 323: 1057-1060.
52. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B.G., Schoenemeyer A., Yamamoto M., Akira S., Fitzgerald K.A.: The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol., 2005; 175: 5260-5268. (Pubitemid 41456411)
53. Saito T., Hirai R., Loo Y.M., Owen D., Johnson C.L., Sinha S.C., Akira S., Fujita T., Gale M.Jr.: Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. USA, 2007; 104: 582-587. (Pubitemid 46123068)
54. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., Tsujimura T., Fujita T., Akira S., Takeuchi O.: LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. USA, 2010; 107: 1512-1517.
55. Schlee M., Hartmann E., Coch C., Wimmenauer V., Janke M., Barchet W., Hartmann G.: Approaching the RNA ligand for RIG-I? Immunol. Rev., 2009; 227: 66-74.
56. Shao W., Yeretssian G., Doiron K., Hussain S.N., Saleh M.: The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem., 2007; 282: 36321-36329.
57. Shaw M.H., Reimer T., Kim Y.G., Nunez G.: NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr. Opin. Immunol., 2008; 20: 377-382.
58. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., Klucher K.M.: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol., 2003; 4: 63-68. (Pubitemid 36104710)
59. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopoulou L., Flavell R.A., Beutler B.: Toll-like receptors 3 and 9 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA, 2004; 101: 3516-3521. (Pubitemid 38338227)
60. Tabeta K., Mack A., Moresco E.M.Y., Beutler B.: Record for CpG1, updated Sep 07, 2010. MUTAGENETIX (TM), B. Beutlerand colleagues, Department of Genetics, The Scripps Research Institute, La Jolla, CA. http://mutagenetix. scripps.edu/(12.11.2010).
61. Takahashi K., Kawai T., Kumar H., Sato S., Yonehara S., Akira S.: Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J. Immunol., 2006; 176: 4520-4524.
62. Takaoka A., Taniguchi T.: Cytosolic DNA recognition for triggering innate immune responses. Adv. Drug Deliv, Rev., 2008; 60: 847-857.
63. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T.: DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 2007; 448: 501-505. (Pubitemid 47123520)
64. Takeda K., Kaisho T., Akira S.: Toll-like receptors. Annu. Rev. Immunol., 2003; 21: 335-376. (Pubitemid 37174535)
65. Takeuchi O., Akira S.: Innate immunity to virus infection. Immunol. Rev., 2009; 227: 75-86.
66. Theofilopoulos A.N., Baccala R., Beutle B., Kono D.H.: Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol., 2005; 23: 307-336.
67. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., Sirois C.M., Jin T., Latz E., Xiao T.S., Fitzgerald K.A., Paludan S.R., Bowie A.G.: IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol., 2010; 11: 997-1004.
68. Uzé G., Monneron D.: IL-28 and IL-29: newcomers to the interferon family. Biochimie, 2007; 89: 729-734. (Pubitemid 47001631)
69. Venkataraman T., Valdes M., Elsby R., Kakuta S., Caceres G., Saijo S., Iwakura Y., Barber G.N.: Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol., 2007; 178: 6444-6455. (Pubitemid 46717428)
70. Vercammen E., Staal J., Beyaert R.: Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin. Microbiol. Rev., 2008; 21: 13-25. (Pubitemid 351160008)
71. Vilaysane A., Muruve D.A.: The innate immune response to DNA. Semin. Immunol., 2009; 21: 208-214.
72. Yanai H., Savitsky D., Tamura T., Taniguchi T.: Regulation of the cytosolic DNA-sensing system in innate immunity: a current view. Curr. Opin. Immunol., 2009; 21: 17-22.
73. Yoneyama M., Fujita T.: Function of RIG-I-like receptors in antiviral innate immunity. J. Biol. Chem., 2007; 282: 15315-15318. (Pubitemid 47093255)
74. Zhang S.Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L., Puel A., Picard C., Chapgier A., Plancoulaine S., Titeux M., Cognet C., von Bernuth H., Ku C.L., Casrouge A., Zhang X.X., Barreiro L., Leonard J., Hamilton C., Lebon P., Héron B., Vallée L., Quintana-Murci L., Hovnanian A., Rozenberg F., Vivier E., Geissmann F., Tardieu M., Abel L., Casanova J.L.: TLR3 deficiency in patients with herpes simplex encephalitis. Science, 2007; 317: 1522-1527. (Pubitemid 47417427)
75. Zheng M., Klinman D.M., Gierynska M., Rouse B.T.: DNA containing CpG motifs induces angiogenesis. Proc. Natl. Acad. Sci. USA, 2002; 99: 8944-8949. (Pubitemid 34693663)